Document Detail


Interferon alpha 2b for treatment of conjunctival melanoma : A case report.
MedLine Citation:
PMID:  23319061     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
A 71-year-old female patient with a status following multiple conjunctival excisions, histopathologically confirmed conjunctival melanoma (CMM) and also multiple therapy with mitomycin C presented with progressive conjunctival pigmentation. Treatment was carried out with local interferon α2b administration four or five times daily for several months. The lesion showed regression and lost pigmentation without any side effects.
Authors:
C Schumacher; C Heinz; P Lommatzsch; A Lommatzsch; J Koch
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-16
Journal Detail:
Title:  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft     Volume:  -     ISSN:  1433-0423     ISO Abbreviation:  Ophthalmologe     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9206148     Medline TA:  Ophthalmologe     Country:  -    
Other Details:
Languages:  GER     Pagination:  -     Citation Subset:  -    
Affiliation:
Augenabteilung, St. Franziskus Hospital, Hohenzollernring 74, 48145, Münster, Deutschland, c.schumacher@uveitis-zentrum.de.
Vernacular Title:
Interferon-α2b zur Therapie des Bindehautmelanoms : Ein Fallbeispiel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical tr...
Next Document:  Role of energy metabolism in retinal pigment epithelium.